Kolon TissueGene, Inc. (KOSDAQ:950160)

Kolon TissueGene Revenue

Kolon TissueGene had revenue of 819.27M KRW in the quarter ending June 30, 2026, a decrease of -39.02%. This brings the company's revenue in the last twelve months to 4.80B, down -12.58% year-over-year. In the year 2025, Kolon TissueGene had annual revenue of 5.16B with 1.68% growth. That makes Kolon TissueGene the 40,947th largest company in the world by revenue and 2,521st in South Korea.

• Revenue (ttm): 4.80B
• Revenue Growth: -12.58%
• P/S Ratio: 268.20
• Revenue / Employee: 165.40M
• Employees: 29
• Market Cap: 1.29T

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.16B	85.27M	1.68%
Dec 31, 2024	5.07B	1.37B	36.90%
Dec 31, 2023	3.71B	-5.75B	-60.81%
Dec 31, 2022	9.46B	5.45B	136.22%
Dec 31, 2021	4.00B	447.31M	12.58%

Data Source: S&P Global Market Intelligence Last updated: Jul 30, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 12, 2026

Data Sources Report a data error